Seeking Alpha
 

ShangPharma Corporation (SHP)

- NYSE
SHP is defunct.
Show Summaries  |  Hide Summaries
  • Dec. 21, 2012, 9:10 AM
    Premarket gainers: HALO +19%. CEMI +17%. ASCA +17%. APPY +14%. RHT +5%. PNK +5%. SHP +5%.
    Losers: ECTE -18%. RIMM -14%. ALU -7%.
    | 1 Comment
  • Nov. 20, 2012, 6:18 AM
    ShangPharma (SHP): Q3 EPS of $0.15 misses by $0.05. Revenue of $31.9M (+10.6% Y/Y) misses by $2.1M. (PR)
    | Comment!
  • Aug. 20, 2012, 12:23 PM
    ShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also reconfirms its guidance for net revenues for FY12. Net revenues are expected to be approximately $131.7 to $136.2 million, which represents growth of approximately 18% to 22% compared with FY11. William Blair cuts the shares to Market Perform on the report.
    | Comment!
  • Aug. 20, 2012, 7:44 AM
    ShangPharma (SHP): Q2 EPS of $0.11 misses by $0.09. Revenue of $31.8M (+15.7% Y/Y) misses by $1M. (PR)
    | Comment!
  • Jul. 6, 2012, 8:11 AM
    Shares of ShangPharma (SHP) move up 15.1% premarket after the firm receives a "going private" buyout offer from a group of private investors at $8.50-$9.50 per ADS. The company says that it's forming a special committee to study the offer.
    | Comment!
  • Aug. 12, 2011, 11:02 AM
    Chinese biotech research firm ShangPharma (SHP +18.3%) pops after announcing a $10M stock repurchase program. In addition, founder and CEO Michael Xin Hui intends to purchase up to $1M worth of its shares through a personal, family-owned company.
    | Comment!
Visit Seeking Alpha's
Company Description
Currently, there's no company description for SHP.
Sector: Healthcare
Industry: Biotechnology
Country: China